Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Cerullo V" with an ORCID

Vincenzo Cerullo
Helsinki University Centre for Drug Research
89
Publications
3,750
Citations
View profile

Search results

1-25 of 145 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells.
Falanga AP, Greco F, Terracciano M, D'Errico S, Marzano M, Feola S, Sepe V, Fontana F, Piccialli I, Cerullo V, Santos HA, Borbone N
Int J Pharm, 124941, 10 Nov 2024
Cited by: 0 articles | PMID: 39532274
Add to export list
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Feodoroff M, Hamdan F, Antignani G, Feola S, Fusciello M, Russo S, Chiaro J, Välimäki K, Pellinen T, Branca RM, Lehtiö J, D Alessio F, Bottega P, Stigzelius V, Sandberg J, Clancy J, Partanen J, Malmstedt M, Rannikko A, [...] Cerullo V
Oncoimmunology, 13(1):2407532, 25 Sep 2024
Cited by: 0 articles | PMID: 39351443 | PMCID: PMC11441019
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
Ferro C, Matos AI, Serpico L, Fontana F, Chiaro J, D'Amico C, Correia A, Koivula R, Kemell M, Gaspar MM, Acúrcio RC, Cerullo V, Santos HA, Florindo HF
Adv Healthc Mater, e2401523, 29 Aug 2024
Cited by: 0 articles | PMID: 39205539
Add to export list
Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.
Harjunpää H, Somermäki R, Saldo Rubio G, Fusciello M, Feola S, Faisal I, Nieminen AI, Wang L, Llort Asens M, Zhao H, Eriksson O, Cerullo V, Fagerholm SC
Oncoimmunology, 13(1):2369373, 21 Jun 2024
Cited by: 0 articles | PMID: 38915784 | PMCID: PMC11195491
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Translational Aspects of Epithelioid Sarcoma: Current Consensus.
Grünewald TGP, Postel-Vinay S, Nakayama RT, Berlow NE, Bolzicco A, Cerullo V, Dermawan JK, Frezza AM, Italiano A, Jin JX, Le Loarer F, Martin-Broto J, Pecora A, Perez-Martinez A, Tam YB, Tirode F, Trama A, Pasquali S, Vescia M, [...] Antonescu CR
Clin Cancer Res, 30(6):1079-1092, 01 Mar 2024
Cited by: 1 article | PMID: 37916971 | PMCID: PMC10947972
Add to export list Review Free full text in Europe PMC
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.
Feola S, Hamdan F, Russo S, Chiaro J, Fusciello M, Feodoroff M, Antignani G, D'Alessio F, Mölsä R, Stigzelius V, Bottega P, Pesonen S, Leusen J, Grönholm M, Cerullo V
J Immunother Cancer, 12(3):e008342, 08 Mar 2024
Cited by: 0 articles | PMID: 38458776 | PMCID: PMC10928783
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Feola S, Chiaro J, Fusciello M, Russo S, Kleino I, Ylösmäki L, Kekäläinen E, Hästbacka J, Pekkarinen PT, Ylösmäki E, Capone S, Folgori A, Raggioli A, Boni C, Tiezzi C, Vecchi A, Gelzo M, Kared H, Nardin A, [...] Cerullo V
Int J Biol Macromol, 262(pt 1):129926, 06 Feb 2024
Cited by: 0 articles | PMID: 38331062
Add to export list
Exploring the DNA₂-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation.
Falanga AP, Lupia A, Tripodi L, Morgillo CM, Moraca F, Roviello GN, Catalanotti B, Amato J, Pastore L, Cerullo V, D'Errico S, Piccialli G, Oliviero G, Borbone N
Heliyon, 10(3):e24599, 22 Jan 2024
Cited by: 0 articles | PMID: 38317891 | PMCID: PMC10839560
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Russo S, Feola S, Feodoroff M, Chiaro J, Antignani G, Fusciello M, D'Alessio F, Hamdan F, Pellinen T, Mölsä R, Tripodi L, Pastore L, Grönholm M, Cerullo V
Mol Ther Oncol, 32(1):200766, 26 Jan 2024
Cited by: 0 articles | PMID: 38596301 | PMCID: PMC10869747
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, Abbati D, Potenza A, Balestrieri C, Cianciotti BC, Tassi E, Feola S, Toffalori C, Punta M, Magnani Z, Camisa B, Tiziano E, Lupo-Stanghellini MT, Branca RM, [...] Ruggiero E
Sci Adv, 9(48):eadg8014, 01 Dec 2023
Cited by: 0 articles | PMID: 38039364 | PMCID: PMC10691777
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
Garofalo M, Wieczorek M, Anders I, Staniszewska M, Lazniewski M, Prygiel M, Zasada AA, Szczepińska T, Plewczynski D, Salmaso S, Caliceti P, Cerullo V, Alemany R, Rinner B, Pancer K, Kuryk L
Front Oncol, 13:1259314, 20 Nov 2023
Cited by: 1 article | PMID: 38053658 | PMCID: PMC10694471
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.
Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, Russo S, Fusciello M, Hamdan F, Ferrari V, Ciampi D, Ilonen I, Räsänen J, Mäyränpää M, Partanen J, Koskela S, Honkanen J, Halonen J, Kuryk L, [...] Cerullo V
Nat Commun, 14(1):7056, 03 Nov 2023
Cited by: 3 articles | PMID: 37923723 | PMCID: PMC10624665
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Personalizing Oncolytic Virotherapy.
Hamdan F, Fusciello M, Cerullo V
Hum Gene Ther, 34(17-18):870-877, 01 Sep 2023
Cited by: 1 article | PMID: 37698876
Add to export list Review
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma.
Tripodi L, Feola S, Granata I, Whalley T, Passariello M, Capasso C, Coluccino L, Vitale M, Scalia G, Gentile L, De Lorenzo C, Guarracino MR, Castaldo G, D'Argenio V, Szomolay B, Cerullo V, Pastore L
iScience, 26(10):107668, 19 Aug 2023
Cited by: 7 articles | PMID: 37720092 | PMCID: PMC10502363
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Integrating immunopeptidome analysis for the design and development of cancer vaccines.
Feola S, Chiaro J, Cerullo V
Semin Immunol, 67:101750, 30 Mar 2023
Cited by: 5 articles | PMID: 37003057
Add to export list Review
Cancer immunotherapies: A hope for the uncurable?
Hamdan F, Cerullo V
Front Mol Med, 3:1140977, 17 Feb 2023
Cited by: 5 articles | PMID: 39086690 | PMCID: PMC11285639
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies.
Tripodi L, Sasso E, Feola S, Coluccino L, Vitale M, Leoni G, Szomolay B, Pastore L, Cerullo V
Cancers (Basel), 15(4):1297, 17 Feb 2023
Cited by: 4 articles | PMID: 36831638 | PMCID: PMC9954314
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.
Hamdan F, Feodoroff M, Russo S, Fusciello M, Feola S, Chiaro J, Antignani G, Greco F, Leusen J, Ylösmäki E, Grönholm M, Cerullo V
Mol Ther Oncolytics, 28:264-276, 05 Feb 2023
Cited by: 2 articles | PMID: 36911070 | PMCID: PMC9995465
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Clubb JHA, Kudling TV, Girych M, Haybout L, Pakola S, Hamdan F, Cervera-Carrascon V, Hemmes A, Grönberg-Vähä-Koskela S, Santos JM, Quixabeira DCA, Basnet S, Heiniö C, Arias V, Jirovec E, Kaptan S, Havunen R, Sorsa S, Erikat A, [...] Hemminki A
Front Immunol, 14:1060540, 03 Feb 2023
Cited by: 2 articles | PMID: 36817448 | PMCID: PMC9936529
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mannosylated Polycations Target CD206⁺ Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination.
Bellato F, Feola S, Dalla Verde G, Bellio G, Pirazzini M, Salmaso S, Caliceti P, Cerullo V, Mastrotto F
Biomacromolecules, 23(12):5148-5163, 17 Nov 2022
Cited by: 4 articles | PMID: 36394394 | PMCID: PMC9748946
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Development of mesothelioma-specific oncolytic vaccine exploiting immunopeptidomic analysis of murine and human tumors
Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, Ferrari V, Ciampi D, Ilonen I, Räsänen J, Mäyränpää M, Partanen J, Koskela S, Kuryk L, Russo S, Fusciello M, Hamdan F, Rescigno M, Grönholm M, [...] Cerullo V
Research Square, 08 Nov 2022
Cited by: 0 articles | PPR: PPR569256
Add to export list Preprint v1
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.
Tuovinen EA, Pöysti S, Hamdan F, Le KM, Keskitalo S, Turunen T, Minier L, Mamia N, Heiskanen K, Varjosalo M, Cerullo V, Kere J, Seppänen MRJ, Hänninen A, Grönholm J
J Clin Immunol, 43(2):358-370, 19 Oct 2022
Cited by: 1 article | PMID: 36260239 | PMCID: PMC9892142
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy.
Xu W, Pang C, Song C, Qian J, Feola S, Cerullo V, Fan L, Yu H, Lehto VP
Acta Biomater, 152:473-483, 08 Sep 2022
Cited by: 6 articles | PMID: 36087872
Add to export list
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model.
Vitale M, Scialò F, Passariello M, Leggiero E, D'Agostino A, Tripodi L, Gentile L, Bianco A, Castaldo G, Cerullo V, De Lorenzo C, Pastore L
Front Oncol, 12:902190, 20 May 2022
Cited by: 6 articles | PMID: 35669438 | PMCID: PMC9163395
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella.
Fusciello M, Ylösmäki E, Feola S, Uoti A, Martins B, Aalto K, Hamdan F, Chiaro J, Russo S, Viitala T, Cerullo V
Mol Ther Oncolytics, 25:137-145, 19 Apr 2022
Cited by: 2 articles | PMID: 35572195 | PMCID: PMC9065466
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 145 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Cerullo V" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Cerullo V" with an ORCID